TRACON Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LPL FINANCIAL LLC | 05/10/2024 | 450,650 | $193,689 | 100.00% | 1.38% |
| ACADIAN ASSET MANAGEMENT LLC | 05/10/2024 | 413,909 | $176,000 | 0.00% | 1.26% |
| SQUAREPOINT OPS LLC | 05/15/2024 | 388,985 | $167,186 | -5.65% | 1.19% |
| RENAISSANCE TECHNOLOGIES LLC | 05/13/2024 | 300,238 | $129,000 | 206.25% | 0.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2024 | 286,709 | $123,228 | 37.32% | 0.88% |
| VANGUARD GROUP INC | 05/10/2024 | 262,772 | $112,939 | 0.00% | 0.80% |
| BLACKROCK INC. | 05/10/2024 | 260,084 | $111,784 | -0.45% | 0.79% |
| JANE STREET GROUP, LLC | 05/16/2024 | 182,307 | $78,356 | 100.00% | 0.56% |
| UBS GROUP AG | 05/13/2024 | 91,333 | $39,273 | 100.00% | 0.28% |
| JOHNSON & JOHNSON | 05/10/2024 | 84,003 | $36,104 | 0.00% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/07/2024 | 77,868 | $33,468 | 100.00% | 0.24% |
| STATE STREET CORP | 05/15/2024 | 75,154 | $32,301 | 0.00% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2024 | 74,658 | $32,088 | -61.00% | 0.23% |
| CI PRIVATE WEALTH, LLC | 05/09/2024 | 57,455 | $24,695 | 0.00% | 0.18% |
| HRT FINANCIAL LP | 05/13/2024 | 54,364 | $23,000 | 100.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2024 | 34,822 | $14,966 | 100.00% | 0.11% |
| XTX TOPCO LTD | 05/13/2024 | 27,965 | $12,019 | 100.00% | 0.09% |
| ETF PORTFOLIO PARTNERS, INC. | 05/03/2024 | 24,641 | $10,591 | 100.00% | 0.08% |
| SPIDERROCK ADVISORS, LLC | 04/30/2024 | 22,983 | $8,299 | 100.00% | 0.07% |
| NORTHERN TRUST CORP | 05/14/2024 | 21,691 | $9,323 | 0.00% | 0.07% |
| HOYLECOHEN, LLC | 05/15/2024 | 13,000 | $5,588 | 0.00% | 0.04% |
| JUMP FINANCIAL, LLC | 05/13/2024 | 10,500 | $4,515 | 100.00% | 0.03% |
| BANK OF NEW YORK MELLON CORP | 04/25/2024 | 10,259 | $4,409 | 0.00% | 0.03% |
| MERCER GLOBAL ADVISORS INC /ADV | 05/15/2024 | 10,000 | $4,000 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2024 | 7,579 | $3,259 | -26.88% | 0.02% |
| GAME PLAN FINANCIAL ADVISORS, LLC | 04/12/2024 | 1,000 | $430 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/14/2024 | 318 | $137 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/10/2024 | 207 | $89 | 1.47% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
| GTS SECURITIES LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| IKARIAN CAPITAL, LLC | 05/17/2024 | 0 | $0 | -100.00% | 0.00% |
TRACON Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of TRACON Pharmaceuticals, Inc.. The most heavily invested institutionals were:
HoyleCohen, LLC: 0
BlackRock Inc.: 0
Telemetry Investments, L.L.C.: 97,000
DOWLING & YAHNKE LLC: 47,455
ACT CAPITAL MANAGEMENT, LLC: 28,500
Psagot Value Holdings Ltd.: 143,591
9.91% of TRACON Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 444,279 shares in the last 24 months. This purchase volume represents approximately $13,328 in transactions.